Results 241 to 250 of about 96,603 (330)

APPLICATION OF SELECTIVE ARTERIAL EMBOLIZATION FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN PATIENTS WITH HIGH OPERATIVE RISK

, 2018
С. В. Головко, А. А. Кобірниченко, O. F. Savytskyi, I. L. Troyitskyi   +3 more
openalex   +1 more source

Risk factors for benign prostatic hyperplasia: a comprehensive review. [PDF]

Rev Assoc Med Bras (1992)
Siqueira MHB.
europepmc   +1 more source

Erectile Responses to Intracavernous Papaverine and Phentolamine [PDF]

, 1988
Stief, Christian Georg, Wetterauer, Ulrich   +1 more
core   +1 more source

Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With 225Ac‐ and 177Lu‐Labeled RGD Peptides

Cancer Science, Volume 117, Issue 1, Page 193-202, January 2026.
Radionuclide therapy using PD‐K(225Ac‐DOTA)‐RGD in BxPC‐3‐bearing mice. PD‐K(225Ac‐DOTA)‐RGD successfully suppressed tumor growth. ABSTRACT Improved peptide pharmacokinetics are needed to enhance the therapeutic effects of peptide‐based radionuclide therapy.
Mitsuyoshi Yoshimoto, Shun‐ichi Wada, Yukie Yoshii, Sayaka Hanadate, Anri Inaki, Hirofumi Fujii   +5 more
wiley   +1 more source

Postoperative efficacy of transurethral resection of the prostate (TURP) in treating benign prostatic hyperplasia combined with detrusor underactivity. [PDF]

Medicine (Baltimore)
Xin Y, Li D, Lin S, Gan R, Li L, Zhao Z, Zhao A, Yang C, Li B.   +8 more
europepmc   +1 more source

OR30-06 Local Growth Hormone Triggers Benign Prostate Hyperplasia Development [PDF]

Masaki Ryuzaki, Zonis Svetlana, Sandrine Billet, Hyung L. Kim, Neil A. Bhowmick, Stephen J. Freedland, Ger J. Strous, Vera Chesnokova, Shlomo Melmed   +8 more
openalex   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source

Local and Systemic Effects of Chronic Intracavernous Injection of Papaverine, Prostaglandine E1 and Saline in Primates [PDF]

, 1989
Aboseif, Sherif R., Bosch, Ruud J. L. H., Breza, J., Bénard, Francois, Lue, Tom F., Stackl, W., Stief, Christian Georg, Tanagho, Emil A.   +7 more
core  

Treatment‐related changes in the prostate: past, present and future therapies

Histopathology, Volume 88, Issue 1, Page 40-52, January 2026.
Radiation therapy alters tumour morphology and immunoprofile in prostate cancer. Residual carcinoma shows distorted glandular architecture on H&E and loss of basal markers with preserved AMACR expression by immunohistochemistry, aiding in the recognition of treatment effect in prostate biopsies.
Katrina Collins, Liang Cheng
wiley   +1 more source

Examining the effectiveness of Prostatic hyperplasia education on the level of participant's knowledge and awareness. [PDF]

PLoS One
Krismanuel H, Tjhin P.
europepmc   +1 more source